Position in LLY
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$7,171,392
+$2,439,176 QoQ
Shares Held
5,979
+16.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
#1,451
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kesler, Norman & Wride, LLC holds $19,246,916 across 5 Drug Manufacturers - General names. LLY ranks #2 (37.3% of the industry book) .
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,171,392 | 5,979 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $4,732,216 | 5,145 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $5,555,021 | 5,169 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $3,642,562 | 4,774 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $4,296,769 | 5,512 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $4,341,808 | 5,257 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $3,685,528 | 4,774 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,556,163 | 4,014 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $3,297,393 | 3,642 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $2,322,210 | 2,985 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $420,868 | 722 | Shares | Sole | 2024-01-10 | |
| No filing history on record for this holder in this stock. | ||||||